NAPSA Antikörper
Kurzübersicht für NAPSA Antikörper (ABIN7464999)
Target
Alle NAPSA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Kreuzreaktivität
 - Human
 - 
                                            
Aufreinigung
 - Purified by antigen-affinity chromatography.
 - 
                                            
Immunogen
 - Recombinant protein encompassing a sequence within the center region of human Napsin A. The exact sequence is proprietary.
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
 - 
                                            
Kommentare
 - 
                        
Positive Control: 293T
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 0.57 mg/mL
 - 
                                            
Buffer
 - 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
 - 
                                            
Konservierungsmittel
 - Thimerosal (Merthiolate)
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
 
 - 
                                            
 - 
    
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
 - 
                                            
Andere Bezeichnung
 - napsin A aspartic peptidase
 - 
                                            
Hintergrund
 - Napsin A aspartic peptidase , KAP , Kdap , NAP1 , NAPA , SNAPA,The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. [provided by RefSeq]
 - 
                                            
Molekulargewicht
 - 45 kDa
 - 
                                            
Gen-ID
 - 9476
 - 
                                            
UniProt
 - O96009
 - 
                                            
Pathways
 - Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
 
Target
 -